Oroville council upholds Planning Commission denial of proposed Aegis treatment clinic at Oro Dam Boulevard

The Oroville City Council voted unanimously to deny an appeal and uphold the Planning Commission’s July 24 denial of a conditional use permit for an Aegis medication unit at 1121 Oro Dam Boulevard East, adopting Resolution 9407.

The decision preserves the Planning Commission’s location-based concerns: traffic and pedestrian circulation along Highway 162, the facility’s placement in a busy commercial block, and compatibility with nearby uses. Supporters of the project told the council the clinic would serve Oroville residents who now travel to Chico or Marysville for daily medication.

Applicant Rebecca Mitchell said Aegis operates nearby clinics and that many Oroville-area patients currently travel daily for treatment. Medical director Dr. Waring described the local need and the treatment model, saying, “This need is already happening in your community.” He told the council the medication unit model is brief, clinic-style dosing in the morning and does not create lingering, residential populations at the site.

Aegis representatives described operational details: medication-unit dosing generally during morning hours (presenters said medication pick-ups typically occur within a roughly 6 a.m.–11 a.m. window), supervised dosing with the potential for limited take-home privileges, urine toxicology screening and counseling services, and an on-site “concierge” to manage parking and drop-off flow. The applicant said the site has ample parking and that the company vets local contractors and provides a one-year workmanship guarantee on repairs at its other facilities.

Planning staff and several council members focused discussion on whether the Oroville Municipal Code and the Planning Commission’s evaluation showed the location could safely accommodate the clinic’s expected traffic patterns and pedestrian crossings on Highway 162. Staff noted the city’s code includes a 500-foot proximity consideration for certain medical treatment facilities and pointed to alternatives the applicant could pursue. Several nearby business owners and residents testified that the site’s location, adjacent uses, and traffic flow make it an unsuitable match for this type of facility.

Public commenters were sharply divided. Supporters said expanding local access to medication-assisted treatment would reduce travel barriers and overdoses; one patient navigator described outreach and Narcan distribution efforts in neighboring communities. Opponents and adjacent property owners emphasized traffic safety, pedestrian crossings, and the effect on nearby retail tenants.

After public comment and council questions, Councilmember Reynolds moved to adopt Resolution 9407 denying the appeal and upholding the Planning Commission’s denial of Use Permit UP25-11; the motion passed unanimously.

The council’s action is limited to the location and land-use decision before it; it did not make determinations about the broader medical efficacy of medication-assisted treatment. Staff noted the Planning Commission’s denial was “without prejudice,” and the applicant may pursue alternative sites and resubmit an application that addresses circulation and site-design concerns.

What’s next: the applicant said it has explored other sites and may work with city staff on alternatives. The council vote leaves in place the Planning Commission record and the city’s requirement that a suitable location and site plan be identified before a use permit can be approved.